Welcome to Francis Academic Press

Academic Journal of Medicine & Health Sciences, 2023, 4(2); doi: 10.25236/AJMHS.2023.040206.

Research on the medication rules of the famous Chinese medicine professor Ma Zhanping in the treatment of COPD by data mining


Jiang Li1,3, Zhanping Ma1,2,3

Corresponding Author:
Zhanping Ma

1Shaanxi University of Chinese Medicine, Xianyang, 712046, Shaanxi, China

2Shaanxi Provincial Hospital of Chinese Medicine, Xi'an, 710003, Shaanxi, China

3Famous Traditional Chinese Medicine Ma Zhanping Inheritance Studio, Xi'an, 710003, Shaanxi, China


Objective: To collect and organize the clinical TCM prescriptions of Professor Ma Zhanping in the diagnosis and treatment of chronic obstructive pulmonary disease (COPD), to clarify and analyze the commonly used TCM compatibility of Professor Ma Zhanping in the treatment of COPD, and to summarize his clinical experience in the treatment of COPD. In order to provide some reference for clinical treatment of COPD. Methods: The Chinese medicine prescriptions for COPD treated by Professor Ma Zhanping in the outpatient department of Shaanxi Provincial Hospital of Traditional Chinese Medicine from January 2019 to March 2021 were collected. After screening, data mining techniques such as statistical frequency, association rule analysis, drug network link relationship analysis, and cluster analysis were used, analyze the drug compatibility relationship, summarize the medication rules, and visualize the results. Results: A total of 271 first-diagnostic prescriptions were screened, involving 160 flavors of drugs, and the frequency of use reached 4012 times. Among them, commonly used drugs include bitter almond, ephedra, coix seed, pinellia chinensis and perilla seed. Coix seed, at the same time cluster analysis obtained 4 groups of clusters. Conclusion: Professor Ma Zhanping believes that the treatment of COPD should firstly identify the external and internal injuries, differentiate the syndrome by stages, and choose the prescription flexibly, so as to promote the normalization of qi in the body, and then the qi will be smooth and smooth.


Data mining; COPD; Ma Zhanping; Medication rule

Cite This Paper

Jiang Li, Zhanping Ma. Research on the medication rules of the famous Chinese medicine professor Ma Zhanping in the treatment of COPD by data mining. Academic Journal of Medicine & Health Sciences (2023) Vol. 4, Issue 2: 30-39. https://doi.org/10.25236/AJMHS.2023.040206.


[1] Chronic Obstructive Pulmonary Diseases Group of the Chinese Society of Geriatrics, Respiratory Diseases Branch. Practice guidelines for clinical diagnosis and management of chronic obstructive pulmonary disease in the elderly in China[J]. Chinese Journal of Tuberculosis and Respiratory Diseases,2020,43(02):100-119.

[2] Halpin DMG, Criner GJ, Papi A, et al. Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2021 Jan 1; 203(1):24-36. 

[3] Chronic Obstructive Pulmonary Disease Group of the Chinese Medical Association Respiratory Diseases Branch. Guidelines for the diagnosis and treatment of chronic obstructive pulmonary disease (2013 revised edition)[J]. Chinese Journal of Frontiers in Medicine (electronic version), 2014, 6(02):67-80.

[4] Tang L, Sun D, Yu X, et al. Research progress of Chinese medicine appropriate technology based on the theory of "treating the untreated disease" for the prevention and treatment of patients with chronic obstructive pulmonary disease in the stable stage[J]. World Chinese Medicine, 2021, 16(05):849-854.

[5] Ji Youhong, Wan Wenrong. Clinical research progress in the treatment of acute exacerbation of chronic obstructive pulmonary disease by Chinese medicine [J]. Jiangxi Traditional Chinese Medicine, 2016, 47(08):77-80.

[6] Lai H F, Wang L. Research progress in Chinese medicine treatment of stable chronic obstructive pulmonary disease [J]. Xinjiang Traditional Chinese Medicine, 2019, 37(06):112-114.

[7] Zhong Gansheng. Chinese herbal medicine [M]. Beijing: China Chinese Medicine Press,2017:382.

[8] National Pharmacopoeia Committee. Pharmacopoeia of the People's Republic of China (2020 edition) [M]. Beijing: China Medical Science and Technology Press, 2020.

[9] Li Maqing, Zheng Huan, Wu Haomeng, et al. Exploring the medication pattern of Professor Huang Shaogang's treatment of chronic gastritis based on data mining[J]. China Hospital Medication Evaluation and Analysis,2020, 20(12):1501-1504+1508.

[10] Liu Jiaqi, Kan Shiyun, Zhu Xue et al. Overview of research on the evolutionary pattern of Chinese medical evidence in chronic obstructive pulmonary disease[J]. Journal of Liaoning University of Traditional Chinese Medicine,2019,21(1):76-79.

[11] Huang L, Wang YN, Wu Suyue. Research progress on pharmacological effects of Chinese medicine Ephedra [J]. Chinese and Foreign Medicine,2018,37(07):195-198.

[12] ZHAO Yusheng, HU Jie, WU Jiashu, et al. Research progress on the concoction method and pharmacological effects of bitter almond[J]. Journal of Traditional Chinese Medicine,2021, 27(03):175-180.

[13] Ye Xiaobin. Progress of research on chemical composition and pharmacological effects of commonly used pairs of ephedra[J]. TCM Research,2021, 34(03):57-62.

[14] Luo Huiying, Yang Lin, Yang Huan, et al. Protective effects of angelica volatile oil on focal cerebral ischemia-reperfusion injury in rats[J]. Chinese Clinical Pharmacology and Therapeutics, 2012, 17 (04):387-391.

[15] WANG Zhiwang, SUN Shao-Bo, CHENG Xiao-Li, et al. Effects of angelica volatile oil in a rat bronchial asthma model[J]. Chinese Journal of Immunology, 2013, 29 (11):1142-1145+1150.

[16] Liu SH, Jing XUP. A study on the efficacy of combining Su Zi Qi-Degrading Tang with Western medicine in the treatment of acute exacerbation of chronic obstructive pulmonary disease in the elderly [J]. Shaanxi Traditional Chinese Medicine,2020,41(12):1739-1742.

[17] Liu, Lijun, Yumai-Man, Liu, Huawei. Three experimental cases of Professor Liu Huawei's treatment of respiratory diseases using Qianjin reed stem soup[J]. Clinical Medicine Research and Practice, 2021,6(02):123-125.

[18] ZHANG Haiying, YANG Aidong, YAN Lingling, et al. Effects of adding Qianjin reed stem soup on SIGIRR protein and its mRNA expression in lung tissue of rats with chronic obstructive pulmonary disease[J]. Journal of Liaoning University of Chinese Medicine,2015,17(02):19-22.

[19] Li HN, Mei QH, Lin Huanze, et al. Advances in chemical composition, pharmacological effects and clinical applications of sinkiang[J]. Chinese Pharmacy,2011,22(35):3349-3351.

[20] PENG Deqian, WANG Chan-hong, LIU Yang-yang, et al. Progress in the study of chemical composition and its pharmacological activity of sinkiang [J]. Chinese Modern Applied Pharmacology, 2021,38(03):358-365.